Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jun 27;17(3):eAO4602.
doi: 10.31744/einstein_journal/2019AO4602.

Pelvic floor muscle training alone or in combination with oxybutynin in treatment of nonmonosymptomatic enuresis. A randomized controlled trial with 2-year follow up

[Article in English, Portuguese]
Affiliations
Randomized Controlled Trial

Pelvic floor muscle training alone or in combination with oxybutynin in treatment of nonmonosymptomatic enuresis. A randomized controlled trial with 2-year follow up

[Article in English, Portuguese]
Renata Martins Campos et al. Einstein (Sao Paulo). .

Abstract

Objective: To compare the results of the standard urotherapy alone and associated with pelvic floor muscle training alone, and in combination with oxybutynin in treatment of nonmonosymptomatic nocturnal enuresis.

Methods: A total of 38 children aged 5 to 10 years were randomized into three groups: Group I (n=12) that was submitted to standard urotherapy; Group II (n=15), standard urotherapy associated with pelvic floor muscle training; and Group III (n=11), standard urotherapy associated with pelvic floor muscle training and oxybutynin; the treatment lasted 12 weeks. The assessment tools used were playful bladder diary, and a 48-hour bladder diary, before and after treatment. After 2 years, patients were assessed by telephone using a standardized questionnaire.

Results: The data of children from the three groups were homogeneous at baseline. After 12-week treatment, all children showed improved symptoms and signs of nonmonosymptomatic nocturnal enuresis, but the differences were not significant among the groups. After 2 years, the three groups showed maintenance of treatment results, but no differences among them.

Conclusion: All treatment modalities were effective regarding improved enuresis and lower urinary tract symptoms, but the sample was not large enough to show differences among groups.

Objetivo: Comparar os resultados da uroterapia padrão isolada e associada ao treinamento dos músculos do assoalho pélvico isoladamente e em combinação com a oxibutinina no tratamento da enurese noturna não monossintomática.

Métodos: Trinta e oito crianças entre 5 e 10 anos de idade foram randomizadas em três grupos: Grupo I (n=12) realizou uroterapia padrão; Grupo II (n=15) realizou uroterapia padrão associada ao treinamento muscular do assoalho pélvico; e Grupo III (n=11) realizou uroterapia padrão associada ao treinamento muscular do assoalho pélvico e oxibutinina. O tratamento teve duração de 12 semanas. Os instrumentos de avaliação foram diário miccional lúdico e diário miccional de 48 horas, antes e depois do tratamento. Após 2 anos, os pacientes foram avaliados por telefone, usando um questionário padronizado.

Resultados: Os dados das crianças dos três grupos eram homogêneos no início do estudo. Após 12 semanas de tratamento, todas as crianças apresentaram melhora em relação aos sinais e sintomas de enurese noturna não monossintomática, mas as diferenças não foram significativas entre os grupos. Depois de 2 anos, os resultados do tratamento se mantiveram nos três grupos, mas não houve diferenças entre os grupos.

Conclusão: As três modalidades de tratamento foram eficazes na melhora da enurese e dos sintomas do trato urinário inferior, mas o tamanho da amostra não foi grande o suficiente para mostrar diferenças entre os grupos.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Playful bladder diary
Figure 2
Figure 2. Proper voiding posture for girls
Figure 3
Figure 3. Median of the number of dry nights measured by the playful bladder diary, assessed 7 days before the beginning of treatment (baseline), after 4 weeks of treatment (Time 1), after 8 weeks of treatment (Time 2) and after 12 weeks of treatment (Time 3)

References

    1. Nevéus T. Pathogenesis of enuresis: towards a new understanding. Int J Urol. 2017;24(3):174–182. - PubMed
    1. Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn. 2016;35(4):471–481. - PubMed
    1. Franco I, von Gontard A, De Gennaro M, International Childrens’s Continence Society Evaluation and treatment of nonmonosymptomatic nocturnal enuresis: a standardization document from the International Children’s Continence Society. J Pediatr Urol. 2013;9(2):234–243. - PubMed
    1. Fernández-Pineda I, Pérez Espejo MP, Fernández Hurtado MA, Barrero Candau R, García Merino F. Biofeedback and electrostimulation in the treatment of non monosymptomatic enuresis. Cir Pediatr. 2008;21(2):89–91. Spanish. - PubMed
    1. Ebiloglu T, Ergin G, Irkilata HC, Kibar Y. The biofeedback treatment for non-monosymptomatic enuresis nocturna. Neurourol Urodyn. 2016;35(1):58–61. - PubMed

Publication types